🕵️ Acurx Pharmaceuticals, Inc. ($ACXP)
SEC insider & ownership activity, last 12 months · CIK 1736243 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Apr 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 9, 2026 | filing ↗ |
| Other events (8.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 16, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 31, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 31, 2025 | filing ↗ |
| Other events (8.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |